Skip to main content

Gordon Bernard Archives

Sepsis trial ranked No. 1 on critical care website

Feb. 15, 2018—A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.

Read more


Event showcases REDCap’s data management versatility

Feb. 8, 2018—Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

Read more


Forum highlights strong clinical, translational research efforts

Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.

Read more


VUMC lands renewal of Clinical and Translational Science Award

Jun. 8, 2017—Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).

Read more


Forum highlights research achievements

Feb. 9, 2017—Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.

Read more


American College of Critical Care Medicine honors Bernard

Sep. 29, 2016—Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017.

Read more


New NIH-funded center to study inefficiencies in clinical trials

Jul. 5, 2016—Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

Read more


VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Apr. 4, 2016—Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

Read more


Ten Vanderbilt faculty members elected AAAS fellows

Nov. 23, 2015—Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science.

Read more


New awards honor contributions to translational research at VUMC

Nov. 5, 2015—Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research.

Read more


Initiative seeks to bolster ‘rediscovery research’

Sep. 10, 2015—The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.

Read more


Hartert to help lead Translational Science efforts

Jan. 30, 2014—Tina Hartert, M.D., MPH, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, has been named assistant vice chancellor for Translational Science.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more